Three major health policy issues to watch in 2025

Trump mostly avoided talking about health care during his 2024 campaign, but promised to give RFK Jr. broad rein to shape policy

December 16, 2024 Check out STAT+

Sponsored By

Christine Kao/STAT STAT+ | Three major health care policy issues to watch in 2025 STAT 3 to Watch Series looks at health care policy under a Trump administration: Medicaid cuts, Affordable Care Act premium subsidies, and Medicare reforms. By John Wilkerson STAT+ | FDA authorizes many AI devices for use in kids. Are they validated in a pediatric population? A new study resurfaces long-simmering concerns about the lack of transparency in data used to train and validate AI and ML-enabled devices. By Katie Palmer STAT+ | Novo Holdings is set to close its $16.5 billion acquisition of Catalent after FTC declines to challenge the deal Catalent is an attractive target for Novo Holdings because it is a subcontractor that already helps manufacture the obesity drug Wegovy. By Ed Silverman Courtesy Karla Lewis Photography (Your name here) gene therapy: new fund-raising gambit for family with rare disease The practice of honorary naming is unusual in the drug industry, but it shows the state of the market for rare disease therapies. By Jason Mast STAT+ | Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program Sanofi insisted that its "credit model" will bring transparency by identifying potential duplicate discounts and prevent illegal diversion. By Ed Silverman STAT+ | The AI denial fighters and health care's rising profitability This week in healthcare business news: Using AI to fight insurance denials, Centene backs insurance subsidies, and the latest on Luigi Mangione. By Bob Herman Seth Wenig/Ap Outgoing CDC director girds against an overhaul, and tries to calm staff nerves  As the Trump administration prepares to take over, Mandy Cohen is trying to convince critics the agency has re-focused since its pandemic-era missteps. By Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser